Ignite Creation Date:
2024-05-06 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05735080
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2023-02-09
Brief Title:
Open-Label Study to Evaluate the Safety Tolerability PK and Efficacy of INX-315 in Patients with Advanced Cancer
Sponsor:
Incyclix Bio
Organization:
Incyclix Bio
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Cancer |
| Breast Cancer |
| Breast Cancer Metastatic |
| Hormone Receptor Positive Tumor |
| Human Epidermal Growth Factor 2 Negative Carcinoma of Breast |
| Ovarian Cancer |
| CCNE1 Amplification |
| Solid Tumor |
| Advanced Cancer |